Movement Disorders Journal Podcasts 2012-2015

NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study

Informações:

Synopsis

Movement Disorders Journal Podcasts 2012-2015